• Something wrong with this record ?

Fast Facts: Bladder Cancer

Seth P. Lerner, Ian D. Davis

Published
Basel : S. Karger, 2018
Edition
3rd edition
Pagination
96 stran : ilustrace

Language English Country Germany

Document type Handbook

E-resources

Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease.This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:• the latest understanding of pathology and biology• current standards for investigation, imaging and diagnosis• the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease• the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression• a new chapter about immunotherapy for bladder cancer• future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients.Contents:• Epidemiology and etiology• Pathology and biology• Clinical presentation• Investigations• Management of non-muscle-invasive disease• Management of muscle-invasive disease• Management of advanced and metastatic disease• Immunotherapy• Future trends• Useful resources

Bladder Cancer

Source of Description, Etc.

Print version record

Owner Details Services
NLK NLK Shelf no. ebook [0] see E-resources
000      
02884nam a22002655u 4500
001      
krg277616
003      
CZ-PrNML
005      
20210222091020.0
006      
m o d
007      
cr unu
008      
210217s2018 gw a o 001 0 eng d
009      
eBK
020    __
$a 9781910797655
035    __
$a (OCoLC)1028848893
040    __
$a UKSKG $b cze $c UKSKG $b ABA008 $d ABA008
041    0_
$a eng
044    __
$a gw
100    1_
$a Lerner, Seth P.
245    10
$a Fast Facts: Bladder Cancer / $c Seth P. Lerner, Ian D. Davis
246    00
$a Bladder Cancer
250    __
$a 3rd edition
260    __
$a Basel : $b S. Karger, $c 2018
300    __
$a 96 stran : $b ilustrace
520    __
$a Our understanding of the biology of bladder cancer has advanced remarkably since the second edition of 'Fast Facts: Bladder Cancer' was published in 2006. Five new immunotherapies targeting the PD-1 axis were approved in 2016 and 2017 for the treatment of advanced bladder cancer, reflecting this transformative explosion in knowledge about the biology of the disease.This new era of targeted treatment offers hope to patients, particularly those with advanced disease. However, for clinicians it means a lot to understand in terms of how these immunotherapies are integrated into the treatment paradigm. Who they are suitable for? When are they best used? What is the optimal sequence of treatments for individual patients?This third edition of 'Fast Facts: Bladder Cancer' has been updated extensively throughout by two new authors, bringing a fresh perspective. Key updates include:• the latest understanding of pathology and biology• current standards for investigation, imaging and diagnosis• the critical role that awareness of the significance of hematuria among patients and primary care health professionals can make to earlier detection at curable stages of the disease• the roles of drugs, surgery and radiation therapy in treatment at different stages of bladder cancer, and when and how best to intervene, aided by understanding of the risk factors for disease relapse and progression• a new chapter about immunotherapy for bladder cancer• future trends in a rapidly evolving field.'Fast Facts: Bladder Cancer' is a concise guide that will be of value to clinicians and health professionals involved in the detection and treatment of bladder cancer. This highly readable resource provides a comprehensive and current view of this complex disease, enabling informed discussions with patients.Contents:• Epidemiology and etiology• Pathology and biology• Clinical presentation• Investigations• Management of non-muscle-invasive disease• Management of muscle-invasive disease• Management of advanced and metastatic disease• Immunotherapy• Future trends• Useful resources
588    0_
$a Print version record
650    07
$a urologie $2 czmesh $7 D014572
650    07
$a nádory močového měchýře $7 D001749 $2 czmesh
650    07
$a urologie $7 nlk20040148342 $2 mednas
650    07
$a onkologie $7 nlk20040148136 $2 mednas
655    _7
$a příručky $7 D020479 $2 czmesh
700    1_
$a Davis, Ian D.
776    08
$i Print version: $t Fast Facts: Bladder Cancer $z 9781910797648
856    40
$u https://www.medvik.cz/link/access.do?source=portal&url=https://www.karger.com/Book/Home/277616 $y plný text - pouze pro uživatele NLK $z Karger Fast Facts e-book
910    __
$a ABA008 $b ebook $t l $y x
990    __
$a 20210218 $b ABA008
991    __
$a 20210222090636 $b ABA008
999    __
$a ok $b medvik21 $g 1622925 $s 222028